Introduction
Metabolic syndrome (MetS) presents a significant group of risk factors for cardiovascular morbidity and mortality [1] [2] [3] [4] and constitutes a major public health problem with increasing incidence and prevalence, in recent decades [5] [6] . MetS has been shown to be associated with structural and functional heart disturbances [7] [8] , including left ventricular (LV) diastolic dysfunction [9] [10] , coronary artery disease [11] [12] and arterial and ventricular stiffness [13] [14] . Left atrial (LA) function [15] [16] has been reported to be abnormal due mainly to increased LV filling pressure, which is a reflection of LV cavity stiffness [17] [18] [19] [20] , and is manifested in the form of increased LA volume 21 , and reduced systolic strain, reservoir and overall pump function 15 . These deteriorated heart function seems to be directly related to severity of MetS 15 . LV [22] [23] and LA [24] [25] functions are also known to be abnormal, in heart failure (HF) with preserved LV ejection fraction (HFpEF). However, the potential additional effect of MetS on such abnormalities in HFpEF remains unknown. The aim of this study, therefore, was to investigate the additional effect of MetS on LA reservoir function in HFpEF patients and its potential relationship with symptoms.
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for metabolic syndrome, the presence of 3/5 of the following criteria classified the patients into MetS and non-MetS 26 : 1) abdominal obesity i.e. waist circumference ≥ 94cm for male and ≥ 80cm for female; 2) triglycerides level ≥1.7 mmol; 3) HDL cholesterol <1.0 mmol/L for male and <1.3 mmol/L for female; 4) raised blood pressure ≥130/85 mmHg or antihypertensive medications; and 5) insulin resistance/glucose intolerance (fasting plasma glucose ≥ 6.1 mmol/L). A total of 34 age-and gender matched healthy individuals (age 58±10 years), who served as controls, were also studied using the same Doppler echocardiographic protocol, as well as clinical and biochemical assessment. None of the controls had any cardiovascular risk or systemic disease. Patients and controls gave a written informed consent to participate in the study, which was approved by the local Ethics Committee.
Data collection
Detailed history and clinical assessment were obtained in all patients, in whom routine biochemical tests were also performed including lipid profile, blood glucose level, and kidney function tests. Estimated body mass index (BMI) was calculated from weight and height measurements. Waist, hip measurements were also made and waist/hip ratio calculated.
Echocardiographic examination
A single operator performed all echocardiographic examinations using a Philips Intelligent E-33 system (Philips Healthcare, The Netherlands) with a multi-frequency transducer, and harmonic imaging as appropriate. Images were obtained with the patient in the left lateral decubitus position and during quiet expiration. LV end-systolic and end-diastolic dimension measurements were made from the left parasternal long axis view with the M-mode cursor positioned by the tips of the mitral valve leaflets. LV volumes and emptying fraction were calculated from the apical 2 and 4 chamber views using the modified Simpson method. MAPSE was studied by placing the M-mode cursor at the lateral and septal angles of the mitral annulus which displayed the long axis motion in systole and diastole. Total amplitude of long axis motion (MAPSE) was measured as previously described 27 from peak inward to peak outward points. LV long axis myocardial velocities were also studied using Doppler myocardial imaging technique. From the apical 4-chamber view, longitudinal velocities were recorded with the pulsed wave Doppler sample volume placed at the basal part of LV lateral and septal segments. Systolic (s') and early and late (e' and a') diastolic myocardial velocities were measured with the gain optimally adjusted to obtain the thinnest velocity envelope thickness. Mean value of the lateral and septal LV velocities was calculated.
Diastolic LV function was assessed from filling velocities using spectral pulsed wave Doppler with the sample volume positioned at the tips of the mitral valve leaflets, during a brief apnea. Peak LV early (E wave), and late (A wave) diastolic velocities were measured and E/A ratio was calculated. The E/e' was also calculated as the ratio between transmitral E wave and mean lateral and septal e' wave velocities. The isovolumic relaxation time was measured as the time interval between aortic valve closure and mitral valve opening, from the pulsed wave Doppler recording. LV filling pattern was considered 'restrictive' when E/A ratio was >2.0, E wave deceleration time < 140 ms and the transverse left atrium diameter more than 40 mm 28 . Mitral regurgitation severity was assessed by color and continuous wave Doppler and was graded as mild, moderate, or severe according to the relative jet area to that of the left atrium as well as the flow velocity profile, in line with the recommendations of the American Society of Echocardiography 29 . Likewise, tricuspid regurgitation was assessed by color Doppler and continuous-wave Doppler. Retrograde trans-tricuspid pressure drop>35 mmHg was taken as an evidence for pulmonary hypertension 30 . All M-mode and Doppler recordings were made at a fast speed of 100 mm/s with a superimposed ECG (lead II).
LV dyssynchrony measurements
Indirect assessment of LV dyssynchronous function was obtained by measuring total isovolumic time (t-IVT) and Tei index. Total LV filling time was measured from the onset of the E wave to the end of the A wave and ejection time from the onset to the end of the aortic Doppler flow velocity. Total isovolumic time (t-IVT) was calculated as 60 -(total ejection time + total filling time) and was expressed in s/min 31 . Tei index was calculated as the ratio between t-IVT and ejection time 32 . . LA maximum volume (LA end-systolic volume) was measured at the end of LV systole, just before the opening of the mitral valve, LA minimum volume (LA enddiastolic volume) was measured at end diastole, at the time of closure of the mitral valve, and total LA EF was calculated using the formula Total LA EF = Vmax -Vmin / Vmax 33, 34 .
Statistical analysis
Data are presented as mean ± SD or proportions (% of patients). Continuous data was compared with two-tailed unpaired Student t test and discrete data with Chi-square test. Patients were divided according to the presence of the MetS into HFpEF with MetS and non-MetS, and were compared using unpaired Student t test. For the multivariate prediction of NYHA class, the ordinal regression was used.
Results

Clinical and biochemical data in HFpEF patients vs. Controls
Patients with HFpEF had more prevalent diabetes (p=0.026), and had higher glycaemic levels (p<0.001), triglycerides (p=0.01), urea and creatinine (<0.001, for both) and BMI (p=0.001) compared with controls (Table 1 ). All other clinical and biochemical data were not different between the two groups. LV and LA structure and function in HFpEF patients vs. Controls Patients with HFpEF had thicker interventricular septum and posterior LV wall (p<0.011) for both), higher LV mass index (p=0.001), larger aortic root (p=0.003), reduced septal and lateral MAPSE (p=0.002 and p<0.001, respectively), higher E wave (p<0.001), lower E/A ratio (p=0.022), lower lateral and septal e' (p=0.022, for both), higher E/e' (p<0.001), longer t-IVT (p=0.005) and higher Tei index (p=0.001) compared to controls. LV dimensions and EF were not different between groups (Table 4) . LA diameter, its maximal and minimal volume were significantly larger (p<0.001, p=0.01 and p=0.019, respectively), and LA EF lower in HFpEF patients compared to controls (Table  2) .
Clinical and biochemical data in HFpEF patients, MetS vs non-MetS
Patients with MetS had more prevalent diabetes (p<0.001), higher glycaemic levels (p=0.001), arterial hypertension (p=0.011), cholesterol and triglycerides (p=0.029 and p=0.001, respectively), BMI (p=0.008) and waist/hip ratio (p=0.041) compared with non-MetS ( Table 3 ). The other clinical and biochemical data were not different between groups.
LV and LA structure and function in HFpEF patients, MetS vs No-MetS
Patients with MetS had thicker interventricular septum and posterior LV wall (p=0.011 and p=0.005, respectively), larger end-diastolic volume (p=0.033), higher LV mass index (p=0.038) and lower lateral and septal e' (p=0.001 and p=0.003, respectively) compared with non-MetS, but LV dimensions and EF were not different (Table 4 ). In the MetS group, LA minimal volume was also larger (p=0.007) and LA EF lower (p<0.001, Table 2 , Figure 1 ), than those with non-MetS ( Table 4) .
Predictors of NYHA class
In ordinal regression multivariate analysis, age (p=0.005), LA diameter (p=0.03) and the presence of MetS (p=0.047) were independent predictors of NYHA class in HFpEF patients (Table  5) .
Discussion Findings
The main finding of our study was that despite no difference in LV systolic function between patients with HFpEF and controls, the former had clear evidence for increased LV wall thickness and overall cavity mass, compromised long axis amplitude and velocities as well as worse diastolic function in the form of higher E/A, E/e' and dyssynchrony as shown by high Tei index and longer t-IVT. LA volumes were also larger and its emptying fraction lower than controls. In addition, patients with MetS had worse LA structure and reservoir function compared to non-MetS. Finally, age, LA diameter and MetS were the only independent predictors of NYHA class in this HFpEF population.
Data interpretation
Our findings confirm previous data in showing maintained LV systolic function in HFpEF patients compared to controls despite having myocardial hypertrophy. LV subendocardial function in the form of long axis amplitude of motion and HFpEF: heart failure with preserved ejection fraction; LV: left ventricle; MAPSE: mitral annular plane systolic excursion; Figure: Left atrial ejection fraction (LA EF) in patients with heart failure and preserved ejection fraction (HFpEF), without and with metabolic syndrome (MetS) velocities were significantly reduced in patients, particularly those with MetS. These findings are also similar to what has previously been found in HFpEF 35, 36 , thus suggesting a significant pathology that affects the subendocardial layer of the myocardium rather than the transmural function. Of note, the same subendocardial disturbances were worse in the MetS patients compared to non-MetS, again suggesting an even better explanation for those abnormalities. In the absence of significant epicardial coronary artery disease, a number of mechanisms could be playing a part in this pathology, specifically those related to MetS. Metabolic syndrome induces multiple complex metabolic disturbances including altered insulin signalling, glyco-and lipotoxicity, increased cytokine activity and intramyocyte and/or interstitial deposition of triacylglycerol and AGEs, which may all directly or indirectly affect myocardial function 37 . These factors also trigger endothelial dysfunction 38 which causes dysregulation of vascular permeability, inflammatory responses, and vascular remodeling, mediated by increased vascular tone and arterial stiffness, blood pressure and pulse pressure 39 . The increased afterload, caused by the latter, results in increased myocardial work and consecutively oxygen consumption, resulting in increased energy demand, impaired myocardial perfusion and reduced cardiac efficiency 40 . This energy demand/ supply mismatch induces myocardial hypertrophy, autonomic dysfunction and LV diastolic dysfunction, which was profound in our HFpEF patients, particularly those with MetS.
The second interesting finding of this study was the enlarged LA with reduced LA emptying fraction. This finding suggest an alteration in pulmonary capillary wedge pressure independent of LV systolic function, as was previously shown 41 . Anatomical studies show that LV long axis (subendocardial) function is closely related to LA function 42 . This dependency relationship comes about through the shared mitral annulus as the site of insertion for the longitudinal ventricular (subendocardial) fibers as well as the longitudinal LA myocardial fibers. Indeed, Sir Arthur Keith, over a century ago, had shown this anatomical relationship and described the function of one cavity to depend on that of the other, with one contracting while the other is relaxing and vice versa 43 . With the ventricular longitudinal function impaired in MetS, as explained above, that of the LA is inevitably impaired too, which eventually results in established LA enlargement, being the collecting chamber, with its reservoir function reduced. This finding is also supported by Laplace law 44 , and together explains the high prevalence of atrial fibrillation in HFpEF patients as previously shown 45 .
The third finding in this study is the evidence for LV remodeling which is shown in the form of prolonged t-IVT and raised Tei index, the two are conventionally taken as markers of dyssynchrony and remodeling, which are affected by age 46 . Despite their presence, it seems that the extent of LV remodeling in this cohort was not strong enough to be able to predict severity of patients' symptoms as shown by the NYHA class, when compared with LA dysfunction and the presence of MetS. Indeed the enlargement of the LA diameters and volumes as well as the fall in its emptying fraction suggests and evidence for LA remodeling which itself predicted NYHA class of our patients. This finding is supported by several other studies which showed that LA enlargement and/or its dysfunction are independent predictors of clinical outcome in HF patients 34, 47, 48 , as well as exercise capacity [49] [50] [51] . While the latter disturbances can be explained on the basis of MetS affecting LV subendocardium, a direct effect of MetS on LA myocardium, through its microcirculation remains to be explored.
Study limitations
The relatively small number of patients in the two subgroups MetS and non-MetS is an important limitation of this study. Also, information on the duration of MetS individual risk factors was not available, this would have likely added to a precise determination of their predictive value. Assessment of LA intrinsic myocardial function by speckle tracking could have helped in differentiating primary LA pathology from a secondary one that is influenced by LV log axis dysfunction.
Clinical implications
In patients with HFpEF, the additional MetS adds to further deterioration of cardiac function, particularly the long axis function as well as left atrial function. The enlarged left atrial volume and reduced emptying fraction predict patient's limiting symptoms according to NYHA class. Thus, assessing MetS and LA reservoir function routinely in breathless patients should shed light on its exact mechanism.
Conclusions
Metabolic syndrome worsens LV subendocardial function as well left atrial reservoir function. While the two could be interrelated, direct effect of MetS on LA reservoir function remains to be explored in view of their significant prediction of patients' symptoms. Also, monitoring these two variables in HFpEF should add more insight into the pathophysiology of the condition.
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